To screen the capability of these STING gain-of-function mutants in blocking tumor proliferation, we constructed MIA PaCa-2 cells stably expressing either doxycycline (dox)-inducible wild-type (WT) STING or one of the STING mutants. This evidence concerns the gene STING1 and neoplasm.